Nasdaq GlobeNewswire

Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

Del

TORONTO, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. ("Khiron" or the "Company") reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration ("DEA") Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.

Advisory Board Appointment

Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a Career Special Agent (25 years) with the DEA, he served in a multitude of positions prior to founding the Pharma Compliance Group (PCG).  Mr. Murphy is an internationally recognized security expert in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. He currently serves as President of PCG, which consults to US based controlled substance manufacturers, distributors, and retail pharmacy entities to ensure pharmaceutical regulatory compliance. Mr. Murphy will support the Company by advising on the implementation of closed loop systems to prevent product diversion and to enhance protocols across Khiron's plant to patient value chain.       

Commentary

Mr. Matthew Murphy, comments: "As a leader in compliance enforcement in the early days of the current global opiate crisis, I strived to hold all parties accountable and create a safer system for all participants. As that situation has sadly deteriorated, it has become clear to me it is time for alternative solutions. While observing the evolution of the global legal medical cannabis market as well as Colombia's entrance, I firmly believe Khiron embodies best in class approaches to quality production and security within a robust federal regulatory framework."

Mr. Alvaro Torres, President and CEO of Khiron, comments: "We are very pleased to welcome Mr. Murphy to the advisory board. Mr. Murphy is highly regarded by both his former peers at the DEA and throughout private industry.  He is an excellent addition to our team. His appointment is a testament to our commitment of ensuring regulatory compliance and world-class security measures consistent with the most stringent requirements for controlled substances in every jurisdiction where we operate."

About Khiron Life Sciences Corp.

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis company with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages, and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America.

On behalf of the Board of Directors

"Alvaro Torres" 
Chief Executive Officer 
Direct: +57 (320) 4950326
Email: aftorres@khiron.ca  

"Darren Collins" 
Chief Financial Officer 
Direct: +1 (705) 527 3564
Email: dcollins@khiron.ca  

Further information on the Company can be accessed through the link below:

www.khiron.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, Khiron assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Khiron Life Sciences Corp. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Tenaris Announces 2017 Fourth Quarter and Annual Results21.2.2018 23:49Pressemelding

Tenaris S.A. / Tenaris Announces 2017 Fourth Quarter and Annual Results . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. The financial and operational information contained in this press release is based on audited consolidated financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Net cash / debt and Free Cash Flow. See exhibit I for more details on these alternative performance measures. LUXEMBOURG, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE:TS) (BAE:TS) (BMV:TS) (MILAN:TEN) ("Tenaris") today announced its results for the fourth quarter and year ended December 31, 2017 with comparison to its results for the fourth quarter and year e

InnovMetric Acquires Prefixa Vision Systems21.2.2018 21:22Pressemelding

Consolidates its market presence in Mexico QUEBEC CITY, Feb. 21, 2018 (GLOBE NEWSWIRE) -- InnovMetric Software Inc., the leading provider of universal 3D metrology software solutions, today announced the acquisition of Prefixa Vision Systems, its PolyWorks® Master distributor in Mexico, following five years of successful cooperation. "The growth of the automotive industry in Mexico has been so phenomenal in recent years that in our latest fiscal year Mexico became the 5th largest PolyWorks market in the world. InnovMetric is deeply committed to expanding its local technical expertise to assist its Mexican customers in their successful migration to the PolyWorks universal 3D metrology software platform," said Marc Soucy, President of InnovMetric. The acquisition allows InnovMetric to expand the capabilities of its local subsidiary, PolyWorks Mexico, which include supporting and training Mexican customers and assisting local metrology hardware partners. PolyWorks Mexico will also market

Taconic Biosciences Announces the Formation of Scientific Advisory Board21.2.2018 19:13Pressemelding

RENSSELAER, N.Y., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced the formation of its Scientific Advisory Board (SAB) with the initial appointments of J. Victor Garcia, PhD, Andrew Goodman, PhD, and David Hill, PhD. The SAB will collaborate with Taconic's management in providing scientific insight and guidance on the evolution of the company's product and service portfolios. Capitalizing on Taconic's existing leadership in both the microbiome and immuno-oncology spaces, the SAB members bring complementary expertise to continue to drive innovation in these and other research areas. "Discovery and pre-clinical animal models continue to move toward highly-complex and high-value translational models. To continue to provide the best solutions for our customers, it is essential for Taconic to have guidance from prominent scientific experts as we develop and validate new models and services," sha

SD-WAN Market Leader Aryaka Further Expands UK and EMEA Market Reach with Intergence Partnership21.2.2018 16:01Pressemelding

Partnership Enables More UK and EMEA Enterprises to Adopt Global SD-WAN as-a-Service LONDON, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, today announced that Cambridge, UK-based Intergence will deploy Aryaka's global SD-WAN solution to enhance global connectivity and application performance for its enterprise customers with offices in the UK and Europe. Partnering with Aryaka strengthens Intergence's infrastructure services proposition for its global enterprise customers. Intergence comprises a team of IT infrastructure experts that help organizations realize their digital transformation objectives. Formed in 2003, the company uses innovative technologies like its Stratiam(TM) solution to provide CIOs with insights about IT performance and the customer's digital experiences, and to simplify complex IT problems. Intergence's infrastructure services provide IT leaders with greater flexibility, agility, and cost efficiency. The partnership will enable In

TrueCommerce Dynamics 365 Solution Featured on Microsoft AppSource21.2.2018 16:00Pressemelding

TrueCommerce Solution Delivers Powerful Supply Chain Integration Capabilities to Dynamics 365 Community PITTSBURGH, Feb. 21, 2018 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity and integration solutions, has announced today that its Microsoft Dynamics 365 solution is available on Microsoft AppSource. Built exclusively for and within the native Dynamics 365 platform, the embedded solution connects directly with TrueCommerce's global commerce network, offering immediate access to more than 92,000 pre-connected retailers, marketplaces, distributors, vendors and logistics providers. "Our solution for Dynamics 365 offers a multi-company, multi-deployment architecture that scales to support complex enterprise requirements," said TrueCommerce president Ross Elliott. "We are excited to be selected as one of the few EDI solutions to be featured on Microsoft AppSource, recognition of having achieved Microsoft's highest standards for quality and reliability fo

Colliers International Named to IAOP® Global Outsourcing 100 List for 13th Consecutive Year21.2.2018 15:00Pressemelding

International Association of Outsourcing Professionals® Honors Colliers in Its Annual Listing of the World's Best Outsourcing Service Providers TORONTO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI) (TSX:CIGI) is pleased to announce that it has again been selected for The 2018 Global Outsourcing 100 list by IAOP®, an honor the company has earned for 13 straight years, more than any other real estate services provider. Colliers has been named to the list each year since its inception. Colliers is committed to leadership in the global outsourcing industry and has a proven track-record in the space. The company's outstanding growth continues through a focus on maintaining the most collaborative and creative culture in the industry, allowing clients to accelerate their success by sharing its market-leading expertise. "We are honored to again receive this prestigious recognition from IAOP," said Dylan Ta

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom